|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM316338095 |
| 003 |
DE-627 |
| 005 |
20231225160851.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202003214
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1054.xml
|
| 035 |
|
|
|a (DE-627)NLM316338095
|
| 035 |
|
|
|a (NLM)33064322
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Liang, Shuang
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 12.08.2021
|
| 500 |
|
|
|a Date Revised 12.08.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2020 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Ultrasound (US)-triggered sonodynamic therapy (SDT), as a promising noninvasive therapeutic modality, has received ever-increasing attention in recent years. Its specialized chemical agents, named sonosensitizers, are activated by low-intensity US to produce lethal reactive oxygen species (ROS) for oncotherapy. Compared with phototherapeutic strategies, SDT provides many noteworthy opportunities and benefits, such as deeper penetration depth, absence of phototoxicity, and fewer side effects. Nevertheless, previous studies have also demonstrated its intrinsic limitations. Thanks to the facile engineering nature of nanotechnology, numerous novel nanoplatforms are being applied in this emerging field to tackle these intrinsic barriers and achieve continuous innovations. In particular, the combination of SDT with other treatment strategies has demonstrated a superior efficacy in improving anticancer activity relative to that of monotherapies alone. Therefore, it is necessary to summarize the nanomaterial-assisted combinational sonodynamic cancer therapy applications. Herein, the design principles in achieving synergistic therapeutic effects based on nanomaterial engineering methods are highlighted. The ultimate goals are to stimulate the design of better-quality combined sonodynamic treatment schemes and provide innovative ideas for the perspectives of SDT in promoting its future transformation to clinical application
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a combination therapy
|
| 650 |
|
4 |
|a nanomaterials
|
| 650 |
|
4 |
|a sonodynamic therapy
|
| 650 |
|
4 |
|a sonosensitizers
|
| 700 |
1 |
|
|a Deng, Xiaoran
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ma, Ping'an
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Cheng, Ziyong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lin, Jun
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 32(2020), 47 vom: 01. Nov., Seite e2003214
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:32
|g year:2020
|g number:47
|g day:01
|g month:11
|g pages:e2003214
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202003214
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 32
|j 2020
|e 47
|b 01
|c 11
|h e2003214
|